GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (XCNQ:OPTI) » Definitions » Cash Flow from Financing

Optimi Health (XCNQ:OPTI) Cash Flow from Financing : C$0.86 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Optimi Health Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2024, Optimi Health paid C$0.00 Mil more to buy back shares than it received from issuing new shares. It spent C$0.01 Mil paying down its debt. It paid C$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received C$0.00 Mil from paying cash dividends to shareholders. It received C$0.32 Mil on other financial activities. In all, Optimi Health earned C$0.31 Mil on financial activities for the three months ended in Dec. 2024.


Optimi Health Cash Flow from Financing Historical Data

The historical data trend for Optimi Health's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health Cash Flow from Financing Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Cash Flow from Financing
- 19.18 1.19 3.76 3.20

Optimi Health Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.99 0.99 0.55 - 0.31

Optimi Health Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Optimi Health's Cash from Financing for the fiscal year that ended in Sep. 2024 is calculated as:

Optimi Health's Cash from Financing for the quarter that ended in Dec. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.86 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimi Health  (XCNQ:OPTI) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Optimi Health's issuance of stock for the three months ended in Dec. 2024 was C$0.00 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Optimi Health's repurchase of stock for the three months ended in Dec. 2024 was C$0.00 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Optimi Health's net issuance of debt for the three months ended in Dec. 2024 was C$-0.01 Mil. Optimi Health spent C$0.01 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Optimi Health's net issuance of preferred for the three months ended in Dec. 2024 was C$0.00 Mil. Optimi Health paid C$0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Optimi Health's cash flow for dividends for the three months ended in Dec. 2024 was C$0.00 Mil. Optimi Health received C$0.00 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Optimi Health's other financing for the three months ended in Dec. 2024 was C$0.32 Mil. Optimi Health received C$0.32 Mil on other financial activities.


Optimi Health Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Optimi Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimi Health Business Description

Traded in Other Exchanges
Address
21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
Executives
Dane Nicholas Stevens Director, Senior Officer
Bryan Edward Safarik Director, Senior Officer
William John Ciprick Senior Officer
Jacob Frederick Safarik Director, Senior Officer
Jonathan Schintler Director
John James Wilson Director
Michael Alan Stier Director